AMY WOLCOTT: Open Payments
NPI 1417300641 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$127 in 5 payments from 4 companies in 2025. Trend: 2023 $92 · 2024 $182 · 2025 $127
Food & beverage: $127
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| Indivior Inc. | 1 | $20 |
Products named: FANAPT, CAPLYTA, UZEDY, SUBLOCADE.
Industry payments across NY — which companies pay providers there.
